Amgen 2nd-quarter profit tops Street view, raises 2016 forecast

July 27, 2016 8:06 PM

39 0

July 27 Amgen Inc on Wednesday reported higher-than-expected second-quarter profit on increased sales of its blockbuster rheumatoid arthritis drug Enbrel and newer medicines, and the company again raised its full-year forecast.

The world's largest biotechnology company by market value said net profit rose to $1.87 billion, or $2.47 per share, from $1.65 billion, or $2.15 per share, a year ago.

Read more

To category page